Cited by 160Clusterin in disease pathologyCell death mechanisms and regulationHeat shock proteins research

Intracellular Clusterin Inhibits Mitochondrial Apoptosis by Suppressing p53-Activating Stress Signals and Stabilizing the Cytosolic Ku70-Bax Protein Complex

Open access
Trougakos, Ioannis P., Lourda, Magda, Antonelou, Marianna H., Kletsas, Dimitris, Gorgoulis, Vassilis G., Papassideri, Issidora S., Zou, Yonglong, Margaritis, Lukas H. +2 more·2009·Clinical Cancer Research

Published version of a preprint

Abstract

Purpose: Secretory clusterin (sCLU)/apolipoprotein J is an extracellular chaperone that has been functionally implicated in DNA repair, cell cycle regulation, apoptotic cell death, and tumorigenesis. It exerts a prosurvival function against most therapeutic treatments for cancer and is currently an antisense target in clinical trials for tumor therapy. However, the molecular mechanisms underlying its function remained largely unknown. Experimental Design: The molecular effects of small interfering RNA-mediated sCLU depletion in nonstressed human cancer cells were examined by focusing entirely on the endogenously expressed sCLU protein molecules and combining molecular, biochemical, and microscopic approaches. Results: We report here that sCLU depletion in nonstressed human cancer cells signals stress that induces p53-dependent growth retardation and high rates of endogenous apoptosis. We discovered that increased apoptosis in sCLU-depleted cells correlates to altered ratios of proapoptotic to antiapoptotic Bcl-2 protein family members, is amplified by p53, and is executed by mitochondrial dysfunction. sCLU depletion-related stress signals originate from several sites, because sCLU is an integral component of not only the secretory pathway but also the nucleocytosolic continuum and mitochondria. In the cytoplasm, sCLU depletion disrupts the Ku70-Bax complex and triggers Bax activation and relocation to mitochondria. We show that sCLU binds and thereby stabilizes the Ku70-Bax protein complex serving as a cytosol retention factor for Bax. Conclusions: We suggest that elevated sCLU levels may enhance tumorigenesis by interfering with Bax proapoptotic activities and contribute to one of the major characteristics of cancer cells, that is, resistance to apoptosis.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1158/1078-0432.ccr-08-1805

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • CLU gene encodes clusterin or APOJ that besides its functions in lipid transport, membrane recycling, cell adhesion, and apoptosis affects transvascular Aβ clearance by promoting Aβ42 efflux across the BBB.

    “CLU gene encodes clusterin or APOJ that besides its functions in lipid transport, membrane recycling, cell adhesion, and apoptosis (90, 444, 600, 677) affects transvascular A 𝛃 clearance by promoting A 𝛃 42 efflux across the BBB (580).”

    From Blood-Brain Barrier: From Physiology to Disease and Back (2019) · cites this paper as [600]

    The paper’s introductory passage identifies clusterin as apolipoprotein J and the predominant product of the human CLU gene; the Purpose and Conclusions passages discuss its role in apoptosis (pages not provided). The cited portion of the sentence also lists lipid transport, membrane recycling, and cell adhesion, which these passages and searches of the full-text copy do not support. The separate claim about Aβ42 efflux across the BBB is attached to citation 580, not this source. (LLM, conf=0.88)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 37

  1. [1]de Silva HV Harmony JA Stuart WD Gil CM Robbins J Apolipoprotein J: structure and tissue distribution Biochemistry 1990 29 5380 5389 1974459
  2. [2]Wilson MR Easterbrook-Smith SB Clusterin is a secreted mammalian chaperone Trends Biochem Sci 2000 25 95 98 10694874
  3. [3]Trougakos IP Gonos ES Clusterin/apolipoprotein J in human aging and cancer Int J Biochem Cell Biol 2002 34 1430 1448 12200037
  4. [4]Leskov KS Klokov DY Li J Kinsella TJ Boothman DA Synthesis and functional analysis of nuclear clusterin: a cell death protein J Biol Chem 2003 278 11590 11600 12551933
  5. [5]Caccamo AE Scaltriti M Caporali A Ca2+ depletion induces nuclear clusterin, a novel effector of apoptosis in immortalized human prostate cells Cell Death Differ 2005 12 101 104 15499376
  6. [6]Trougakos IP Gonos ES Regulation of clusterin/apolipoprotein J, a functional homologue to the small heat shock proteins, by oxidative stress in ageing and age-related diseases Free Radic Res 2006 40 1324 1334 17090421
  7. [7]Scaltriti M Santamaria A Paciucci R Bettuzzi S Intracellular clusterin induces G2-M phase arrest and cell death in PC-3 prostate cancer cells Cancer Res 2004 64 6174 6182 15342402
  8. [8]Thomas-Tikhonenko A Viard-Leveugle I Dews M Myc-transformed epithelial cells down-regulate clusterin, which inhibits their growth in vitro and carcinogenesis in vivo Cancer Res 2004 64 3126 3136 15126350
  9. [9]Shannan B Seifert M Leskov K Challenge and promise: roles for clusterin in pathogenesis, progression and therapy of cancer Cell Death Differ 2006 13 12 19 16179938
  10. [10]Viard I Wehrli P Jornot L Clusterin gene expression mediates resistance to apoptotic cell death induced by heat shock and oxidative stress J Invest Dermatol 1999 112 290 296 10084304
  11. [11]Miyake H Chi KN Gleave ME AntisenseTRPM-2 oligodeoxynucleotides chemosensitize human androgen-independent PC-3 prostate cancer cells both in vitro and in vivo Clin Cancer Res 2000 6 1655 1663 10815883
  12. [12]Trougakos IP So A Jansen B Gleave ME Gonos ES Silencing expression of the clusterin/apolipoprotein J gene in human cancer cells using small interfering RNA induces spontaneous apoptosis, reduced growth ability, and cell sensitization to genotoxic and oxidative stress Cancer Res 2004 64 1834 1842 14996747
  13. [13]Criswell T Beman M Araki S Delayed activation of insulin-like growth factor-1 receptor/Src/ MAPK/Egr-1 signaling regulates clusterin expression, a pro-survival factor J Biol Chem 2005 280 14212 14221 15689620
  14. [14]Sallman DA Chen X Zhong B Clusterin mediates TRAIL resistance in prostate tumor cells Mol Cancer Ther 2007 6 2938 2947 18025278
  15. [15]Chi KN Eisenhauer E Fazli L A phase I pharmacokinetic and pharmacodynamic study of OGX-011, a 2′-methoxyethyl antisense oligonucleotide to clusterin, in patients with localized prostate cancer J Natl Cancer Inst 2005 97 1287 1296 16145049
  16. [16]O’Sullivan J Whyte L Drake J Tenniswood M Alterations in the post-translational modification and intracellular trafficking of clusterin in MCF-7 cells during apoptosis Cell Death Differ 2003 10 914 927 12867999
  17. [18]Nizard P Tetley S Le Drean Y Stress-induced retrotranslocation of clusterin/ApoJ into the cytosol Traffic 2007 8 554 565 17451556
  18. [19]Lourda M Trougakos IP Gonos ES Development of resistance to chemotherapeutic drugs in human osteosarcoma cell lines largely depends on up-regulation of clusterin/apolipoprotein J Int J Cancer 2007 120 611 622 17096323
  19. [20]Schlabach MR Luo J Solimini NL Cancer proliferation gene discovery through functional genomics Science 2008 319 620 624 18239126 PMC2981870
  20. [21]Reynolds A Leake D Boese Q Scaringe S Marshall WS Khvorova A Rational siRNA design for RNA interference Nat Biotechnol 2004 22 326 330 14758366
  21. [22]Trougakos IP Lourda M Agiostratidou G Kletsas D Gonos ES Differential effects of clusterin/apolipoprotein J on cellular growth and survival Free Radic Biol Med 2005 38 436 449 15649646
  22. [23]Manders EM Verbeek FJ Aten JA Measurement of co-localization of objects in dual-colour confocal images J Microsc 1993 169 375 382 33930978
  23. [24]Joerger AC Fersht AR Structure-function-rescue: the diverse nature of common p53 cancer mutants Oncogene 2007 26 2226 2242 17401432
  24. [25]Moll UM Wolff S Speidel D Deppert W Transcription-independent pro-apoptotic functions of p53 Curr Opin Cell Biol 2005 17 631 636 16226451
  25. [26]Cohen HY Lavu S Bitterman KJ Acetylation of the C terminus of Ku70 by CBP and PCAF controls Bax-mediated apoptosis Mol Cell 2004 13 627 638 15023334
  26. [27]Hsu YT Youle RJ Nonionic detergents induce dimerization among members of the Bcl-2 family J Biol Chem 1997 272 13829 13834 9153240
  27. [28]Li J Lee AS Stress induction of GRP78/Bi P and its role in cancer Curr Mol Med 2006 6 45 54 16472112
  28. [29]Li J Lee B Lee AS Endoplasmic reticulum stress-induced apoptosis: multiple pathways and activation of p53-up-regulated modulator of apoptosis (PUMA) and NOXA by p53 J Biol Chem 2006 281 7260 7270 16407291
  29. [30]Reddy KB Karode MC Harmony AK Howe PH Interaction of transforming growth factor β receptors with apolipoprotein J/clusterin Biochemistry 1996 35 309 314 8555189
  30. [31]Kang SW Shin YJ Shim YJ Jeong SY Park IS Min BH Clusterin interacts with SCLIP (SCG10-like protein) and promotes neurite outgrowth of PC12 cells Exp Cell Res 2005 309 305 315 16038898
  31. [33]Ruiz-Romero C Lopez-Armada MJ Blanco FJ Mitochondrial proteomic characterization of human normal articular chondrocytes Osteoarthritis Cartilage 2006 14 507 518 16520066
  32. [34]Youle RJ Strasser A The BCL-2 protein family: opposing activities that mediate cell death Nat Rev Mol Cell Biol 2008 9 47 59 18097445
  33. [35]Hoetelmans R van Slooten HJ Keijzer R Erkeland S van deVelde CJ Dierendonck JH Bcl-2 and Bax proteins are present in interphase nuclei of mammalian cells Cell Death Differ 2000 7 384 392 10773823
  34. [36]Koike M Koike A The Ku70-binding site of Ku80 is required for the stabilization of Ku70 in the cytoplasm, for the nuclear translocation of Ku80, and for Ku80-dependent DNA repair Exp Cell Res 2005 305 266 276 15817152
  35. [37]Kim SH Kim D Han JS Ku autoantigen affects the susceptibility to anticancer drugs Cancer Res 1999 59 4012 4017 10463600
  36. [38]Han HJ Russo J Kohwi Y Kohwi-Shigematsu T SATB1 reprogrammes gene expression to promote breast tumour growth and metastasis Nature 2008 452 187 193 18337816
  37. [39]Gorgoulis VG Vassiliou LV Karakaidos P Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions Nature 2005 434 907 913 15829965

Cited by

Sorted by citations

Authors
Trougakos, I. P., Lourda, M., Antonelou, M. H., Kletsas, D., Gorgoulis, V. G., Papassideri, I. S., Zou, Y., Margaritis, L. H., Boothman, D. A., & Gonos, E. S.
Affiliations
  • National Hellenic Research Foundation (GR)
  • 2Department of Cell Biology and Biophysics, Faculty of Biology, and
  • National Centre of Scientific Research "Demokritos" (GR)
  • National and Kapodistrian University of Athens (GR)
  • The University of Texas Southwestern Medical Center (US)
Venue
Clinical Cancer Research
Published
2008-12-31
Volume
15
Issue
1
Pages
48-59
ISSN
  • 1078-0432 (ISSN-L)
  • 1557-3265
OpenAlex
W2114186198
Cited by
160
References
2
Citations by year
2026: 2 · 2025: 2 · 2024: 5 · 2023: 4 · 2022: 11 · 2021: 13 · 2020: 15 · 2019: 11 · 2018: 9 · 2017: 5 · 2016: 7 · 2015: 7 · 2014: 12 · 2013: 15 · 2012: 11
FWCI
5.45
Type
journal article
Language
en
Open access
Locations
  • Clinical Cancer Research (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
  • National Hellenic Research Foundation Helios Repository (National Hellenic Research Foundation) (submittedVersion)
Funders
  • Εθνικό 'Ίδρυμα Ερευνών
  • University of Ioannina
  • Beatson Institute for Cancer Research
  • National Cancer Institute (R01CA078530, P50CA070907, P30CA142543)
  • National Institute of Neurological Disorders and Stroke
Topics
  • Health Sciences › Medicine › Oncology › Clusterin in disease pathology
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Heat shock proteins research
Keywords
secretory clusterin, clusterin, apoptosis, mitochondrial apoptosis, p53, Bax activation, Bcl-2 family proteins, mitochondrial dysfunction, stress signals, tumor cell survival, antisense therapy
MeSH terms
Ku Autoantigen, Cytosol, DNA-Binding Proteins, Humans, Mitochondria, Organelles, Genes, p53, RNA, Small Interfering, Antigens, Nuclear, Cell Line, Tumor, bcl-2-Associated X Protein, Clusterin

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review